Global Artificial Intelligence (AI) Pathology Quality Control Market 2025–2029: Competitive Insights and Opportunities
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Expected Total Market Size Of The Artificial Intelligence (AI) Pathology Quality Control Industry By The Forecast Year 2029?
The artificial intelligence (AI) pathology quality control market has experienced substantial expansion in its size over recent years. This market is projected to grow from $1.46 billion in 2024 to $1.78 billion in 2025, at a compound annual growth rate (CAGR) of 21.6%. Historically, this expansion can be attributed to factors such as the rising prevalence of cancer and chronic diseases, increasing demand for diagnostic accuracy, a shortage of skilled pathologists, rising healthcare expenditure, and the growth in personalized medicine.
The artificial intelligence (AI) pathology quality control market size is anticipated to experience substantial expansion in the coming years. Its size is projected to reach $3.84 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 21.2%. This growth during the projected period is driven by factors such as increasing demand for automated quality assurance, growing investment in healthcare AI startups, the adoption of cloud-based pathology solutions, the expansion of precision medicine initiatives, and a heightened emphasis on the early detection of diseases. Key trends anticipated during the forecast period encompass progress in deep learning algorithms, novelties in quality control (QC) automation tools, the integration of artificial intelligence with digital pathology platforms, the creation of cloud-based pathology solutions, and improvements in multimodal diagnostic analytics.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28124&type=smp
What Are The Main Drivers Boosting The Artificial Intelligence (AI) Pathology Quality Control Industry’s Expansion?
The future expansion of the artificial intelligence (AI) pathology quality control market is anticipated due to the rising need for personalized medicine. Personalized medicine is defined as a healthcare strategy that customizes treatments and preventive measures based on an individual’s distinct genetic profile, lifestyle choices, and environmental factors. The growing uptake of personalized medicine is largely driven by progress in genomics, allowing for accurate identification of genetic differences and the development of customized therapies for patients. Artificial intelligence (AI) pathology quality control improves personalized medicine through the provision of accurate and reliable diagnostic information, facilitating customized treatment plans. This technology lessens diagnostic mistakes by automating quality assessments, thereby boosting precision and dependability, which ultimately promotes healthcare tailored to individual patients. A notable example is that in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023. This represents a substantial rise compared to the 12 approved in 2022. Consequently, the escalating demand for personalized medicine is set to propel the artificial intelligence (AI) pathology quality control market.
How Is The Artificial Intelligence (AI) Pathology Quality Control Market Segmented?
The artificial intelligence (AI) pathology quality control market covered in this report is segmented as
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Digital Pathology, Research, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Software: Image Analysis Software, Diagnostic Decision Support Software, Workflow Management Software, Reporting And Visualization Software
2) By Hardware: Digital Pathology Scanners, Imaging Devices, Servers And Storage Systems, Laboratory Equipment
3) By Services: Implementation Services, Training And Support Services, Maintenance And Upgrade Services, Consulting Services
What Are The Major Trends Driving The Growth Of The Artificial Intelligence (AI) Pathology Quality Control Market?
Leading companies in the artificial intelligence (AI) pathology quality control market are concentrating on developing sophisticated solutions, such as advanced AI-powered offerings, to improve diagnostic precision, optimize laboratory processes, and ensure the reliability of pathology data. These advanced AI-powered solutions refer to next-generation technologies that utilize artificial intelligence to execute complex tasks with increased accuracy, speed, and efficiency. For instance, in November 2023, PathAI, a US-based biotechnology company, launched Artifact Detect 1 on its AISight digital pathology platform. This tool automates the identification and quantification of artifacts in whole slide images (WSI), which are irrelevant morphological features capable of compromising diagnostic accuracy. ArtifactDetect works by automatically pre-screening slides for quality issues, thereby minimizing misdiagnosis and rescans, and consequently enhancing accuracy, laboratory efficiency, and overall throughput. This innovation supports prompt corrective actions like re-staining or re-scanning, ultimately refining the digital workflow and conserving resources for technicians and pathologists.
Which Global Market Leaders Are Shaping The Future Of The Artificial Intelligence (AI) Pathology Quality Control Sector?
Major companies operating in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., and Gestalt Diagnostics LLC.
Download The Full Report For Exclusive Market Findings:
Which Region Is Expected To Witness The Fastest Growth In The Artificial Intelligence (AI) Pathology Quality Control Market?
North America was the largest region in the artificial intelligence (AI) pathology quality control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) pathology quality control report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Artificial Intelligence (AI) Pathology Quality Control Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28124&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) Pathology Quality Control Market 2025, By The Business Research Company
Artificial Intelligence Ai In Predictive Toxicology Global Market Report 2025
Ai In Medical Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Ai In Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
